Comparison of the Efficacy of Dextrose Prolotherapy and Mesotherapy in Lateral Epicondylitis

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2025

Conditions
Lateral Epicondylitis
Interventions
PROCEDURE

Mesotherapy

For 1. group, a solution containing 1 cc each of lidocaine, pentoxifylline, vitamin B complex diluted 1/10 with saline, thiocolchicoside, and meloxicam diluted 1/5 with saline will be made. A 30 gauge, 4 mm mesotherapy injector will be used for the application. The lateral epicondyle will be the site of an intradermal injection. Of that amount, 2.5 cc will be applied point-by-point at intervals of 1-2 cm, and the remaining 2.5 cc will be applied using the napage method, 0.1 cc of solution were given with each injection. This injection will be applied once a week for a total of 4 sessions. Group 2 received dextrose prolotherapy: A 22 gauge syringe was used to apply a total of 5 cc of 15% dextrose solution (a combination of 3.75 ml 20% dextrose and 1.25 mg 2% lidocaine) to at least 5 most sensitive points of the lateral epicondyle. It was injected 3 times with 3 weeks intervals.

Trial Locations (1)

34668

Health Science University Haydarpasa Numune Research and Training Hospital, Istanbul

All Listed Sponsors
lead

Haydarpasa Numune Training and Research Hospital

OTHER

NCT06538194 - Comparison of the Efficacy of Dextrose Prolotherapy and Mesotherapy in Lateral Epicondylitis | Biotech Hunter | Biotech Hunter